Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patients.
Fiche publication
Date publication
décembre 2019
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr AVEROUS Gerlinde, Pr BRIGAND Cécile
Tous les auteurs :
Delhorme JB, Ohayon J, Gouy S, Averous G, Genestie C, Gaichies L, Glehen O, Guilloit JM, Pezet D, Quenet F, Ferron G, Brigand C, Morice P, Honoré C,
Lien Pubmed
Résumé
Psammocarcinoma (PK) is a rare disease of unknown origin. We aimed to report the characteristics, management and survival of patients operated on for PK within the French Network for Rare Peritoneal Malignancies (RENAPE) expert centers.
Mots clés
Intraperitoneal chemotherapy, Ovary, Peritoneum, Psammocarcinoma, Surgery
Référence
Eur J Surg Oncol. 2019 Dec 9;: